from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2886c/-

LFCtreatmentdescriptionclass of inhibitor

-0.235

Amikacinug/mL Amikacintranslation

-0.790

Cap5-10ug/mL Capreomycintranslation

-1.144

Rox10-50 ug/mL Roxithromycintranslation

-0.404

SM2-5 ug/mL Streptomycintranslation

-0.829

Tet5-10 ug/mL Tetracyclinetranslation

-0.087

Rif0.2-5ug/mL Rifampicintranscription

-0.268

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.087

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.024

CPZ10-50 ug/mL Chlorpromazinerespiration

3.578

Clofazimine10-13 ug/mL Clofaziminerespiration

0.173

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

7.160

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.305

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.695

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.479

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.492

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.234

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.424

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.176

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.628

KCN5-20 ug/mL Potassium cyaniderespiration

-0.240

NaN30.2-2 mM Sodium aziderespiration

-1.464

Nigericin50 uM Nigericinrespiration

0.078

TRC10-150 ug/mL Triclosanrespiration

2.811

TRZ10-25 ug/mL Thioridazinerespiration

-0.065

Valinomycin0.5-10 uM Valinomycinrespiration

-0.821

ZnSO42 mM ZnSO4respiration

0.639

menadione6-10 ug/mL Menadionerespiration

0.116

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.384

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.051

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.057

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.651

NRP_1Non-replicating persistence stage 1dosRassociated

-0.511

Amp0.2mg/mL AmpicillincellWall

0.565

Cephalexin20-100 ug/mL CephalexincellWall

-0.286

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.503

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.275

EMB10-20 ug/mL EthambutolcellWall

-0.506

Eta12-40 ug/mL EthionamidecellWall

-0.119

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.286

TLM0.1-0.2 mg/mL ThiolactomycincellWall

2.200

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.325

BZA0.12 mg/mL BenzamidearomaticAmides

-0.080

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.049

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.708

H2O24 mM hydrogen peroxideDNAdamaging

0.214

Levo10 ug/mL LevofloxacinDNAdamaging

0.099

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.711

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.167

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.098

UVUV-irradiationDNAdamaging

1.579

ARP41-4 ug/mL Antitubercular compound ARP4?

0.084

Antimycin12.5-50 ug/mL Antimycin A?

-0.353

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.493

PA_110-50 ug/mL Antitubercular compound PA-1?

0.538

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.180

PA8240.2-2 ug/mL PA-824?

-0.104

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.251

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.048

Verapamil50 uM Verapamil?

-0.060

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.086

methoxatin10-20 ug/mL Methoxatin?